Evrofarma SA (EVROF) — Cash Flow Reinvestment Rate
Latest as of December 2022:
0.41x
Evrofarma SA (EVROF) has a Cash Flow Reinvestment Rate of 0.41x as of December 2022, reinvesting €615.00K (capex €615.00K ) from operating cash flow of €1.52 Million. Check EVROF cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.41x
(Capex + Investments) / Operating CF
Total Reinvested
€615.00K
Capex + Investments
Operating Cash Flow
€1.52 Million
EUR
Capital Expenditures
€615.00K
EUR
Evrofarma SA Cash Flow Reinvestment Rate (2014–2022)
Historical reinvestment intensity for Evrofarma SA across 8 annual periods. Explore long-term investment intensity of Evrofarma SA to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Evrofarma SA (2014–2022)
Year-by-year capital reinvestment analysis for Evrofarma SA. For live market cap and broader valuation context, see EVROF market cap overview.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.84x | €2.05 Million | €2.44 Million | €2.05 Million | ▲ +35.8% |
| 2020 | 0.62x | €904.00K | €1.46 Million | €904.00K | ▲ +26.0% |
| 2019 | 0.49x | €875.00K | €1.78 Million | €875.00K | ▲ +37.2% |
| 2018 | 0.36x | €822.00K | €2.29 Million | €822.00K | ▲ +37.5% |
| 2017 | 0.26x | €810.00K | €3.11 Million | €810.00K | ▲ +9.3% |
| 2016 | 0.24x | €258.00K | €1.08 Million | €258.00K | ▼ -47.5% |
| 2015 | 0.45x | €632.00K | €1.39 Million | €512.00K | ▼ -45.8% |
| 2014 | 0.84x | €727.00K | €866.00K | €607.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow